Amarin (AMRN) Expected to Announce Quarterly Earnings on Wednesday

Amarin (NASDAQ:AMRN - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect Amarin to post earnings of ($0.06) per share and revenue of $32.37 million for the quarter. Parties that wish to register for the company's conference call can do so using this link.

Amarin Trading Down 0.8 %

Shares of NASDAQ:AMRN traded down $0.00 during midday trading on Friday, hitting $0.53. 575,266 shares of the stock were exchanged, compared to its average volume of 1,040,442. Amarin has a twelve month low of $0.43 and a twelve month high of $1.11. The company has a 50 day moving average price of $0.55 and a 200-day moving average price of $0.56. The stock has a market cap of $217.66 million, a P/E ratio of -5.89 and a beta of 1.82.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Amarin from a "sell" rating to a "hold" rating in a report on Friday.

About Amarin

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.